Determinants of Left Ventricular Mass and Hypertrophy in Hemodialysis Patients Assessed by Cardiac Magnetic Resonance Imaging
AUTOR(ES)
Patel, Rajan K.
FONTE
American Society of Nephrology
RESUMO
Background and objectives: Left ventricular hypertrophy (LVH) is an independent risk factor for premature cardiovascular death in hemodialysis (HD) patients and one of the three forms of uremic cardiomyopathy. Cardiovascular magnetic resonance (CMR) is a volume-independent technique to assess cardiac structure. We used CMR to assess the determinants of left ventricular mass (LVM) and LVH in HD patients.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2736694Documentos Relacionados
- Left ventricular volume measured rapidly by oblique magnetic resonance imaging.
- Skeletal Muscle Mass in Acromegaly Assessed by Magnetic Resonance Imaging and Dual-Photon X-Ray Absorptiometry
- Left Ventricular Hypertrophy Evaluation in Obese Hypertensive Patients: Effect of Left Ventricular Mass Index Criteria
- Cardiac Imaging by Nuclear Magnetic Resonance
- Relative effects of left ventricular mass and conduction disturbance on activation in patients with pathological left ventricular hypertrophy.
